Advisory Services Network, LLC Aerie Pharmaceuticals Inc Transaction History

Advisory Services Network, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$11.32 - $16.63 $577 - $848	-51 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$15.16 - $18.97 $773 - $967	51 New	51 $1,000
Q1 2021 May 24, 2021	SELL	$13.12 - $20.9 $669 - $1,065	-51 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$9.12 - $14.49 $465 - $738	51 New	51 $1,000
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $3,090 - $6,660	-261 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$17.72 - $25.1 $4,624 - $6,551	261 New	261 $6,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.